China’s ‘Cutthroat’ Biotech Industry Is Booming. Can Western Companies Still Compete?

The Chinese biotech industry is booming. Competition is steep for U.S. and European counterparts. And it’s unclear whether China’s growing prowess in pharmaceuticals is just what the doctor ordered for industry innovation or a new pain point for domestic drugmakers. Josh Smiley, chief operating officer of Zai Lab, a biotech company headquartered in China and the U.S., discusses what investors need to know.

Check out our daily newsletter! https://get.investors.com/marketdiem/

Get more IBD by subscribing to our channel: https://www.youtube.com/@investorsbusinessdaily

Visit our website: https://www.investors.com
Like us on Facebook: https://www.facebook.com/investorsbusinessdaily
Follow us on X: https://x.com/IBDinvestors
Follow us on Instagram: https://www.instagram.com/investorsbusinessdaily
Follow us on StockTwits: https://stocktwits.com/InvestorsBusinessdaily
Follow us on LinkedIn: https://www.linkedin.com/company/investors-business-daily
Follow us on TikTok: https://www.tiktok.com/@ibdinvestors

Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.

#InvestorsBusinessDaily #ibd